Phosphorylation of Non-muscle Myosin II Regulatory Light Chain by P21-activated Kinase (gamma-PAK)
Overview
Physiology
Affiliations
Myosin regulatory light chain (RLC) phosphorylation has been implicated in Rho-mediated stress fibre formation. The recent observation that Rho kinase phosphorylates RLC in vitro suggests that serine/threonine kinases other than those in the myosin light chain kinase (MLCK) family have the potential to activate myosin II. In this study we report that gamma-PAK, which is activated by the GTP-binding proteins Cdc42 and Rac, catalyses phosphorylation of intact non-muscle myosin II and isolated recombinant RLC. gamma-PAK phosphorylated endothelial cell myosin II to 0.85 +/- 0.02 mol PO4 per mol RLC. Phosphorylation is Ca2+/calmodulin-independent and the enzyme has a K(m) and Vmax for myosin II regulatory light chain of 12 microM and 180 nmol/min/mg respectively. No myosin II heavy chain phosphorylation was detected. Phosphopeptide maps and phosphoamino acid analysis revealed that gamma-PAK phosphorylates Ser-19 but does not phosphorylate Thr-18. A panel of recombinant RLC mutants was used to confirm that Ser-19 is the only phosphorylation site modified by gamma-PAK. On substitution of both Ser-19 and Thr-18 with Ala or Glu, no phosphorylation of other Ser/Thr residues in the RLC was detected. Similar to MLCK, Arg-16 is required for interaction of gamma-PAK with the substrate, since converting Arg-16 to Ala significantly reduced RLC phosphorylation. Endothelial cell monolayers permeabilized with saponin retract upon exposure to either Cdc42 or trypsin-activated gamma-PAK and ATP. Activation of gamma-PAK is required to initiate Ca2+/calmodulin-independent cell retraction and actin rearrangement. Taken together, these data suggest that myosin II activation by the p21-activated family of kinases may be physiologically important in regulating cytoskeletal organization.
Xu H, Wang D, Ramponi C, Wang X, Zhang H Int J Drug Discov Pharm. 2025; :5.
PMID: 39899001 PMC: 7617276. DOI: 10.53941/ijddp.v1i1.179.
Cell blebbing novel therapeutic possibilities to counter metastasis.
Jia W, Czabanka M, Broggini T Clin Exp Metastasis. 2024; 41(6):817-828.
PMID: 39222238 PMC: 11607095. DOI: 10.1007/s10585-024-10308-z.
Tai Y, Goodrich R, Maldonado M, Ortiz J, Martinez J, Ico G Mater Today Bio. 2024; 26:101109.
PMID: 38883422 PMC: 11180340. DOI: 10.1016/j.mtbio.2024.101109.
Joshua I, Lin M, Mardjuki A, Mazzola A, Hofken T Int J Mol Sci. 2023; 24(21).
PMID: 37958899 PMC: 10647699. DOI: 10.3390/ijms242115916.
Scribble, Lgl1, and myosin IIA interact with α-/β-catenin to maintain epithelial junction integrity.
Abedrabbo M, Sloomy S, Abu-Leil R, Kfir-Cohen E, Ravid S Cell Adh Migr. 2023; 17(1):1-23.
PMID: 37743653 PMC: 10761038. DOI: 10.1080/19336918.2023.2260645.